Mitoxantrone as a TRAIL-sensitizing agent for glioblastoma multiforme. (December 2016) - Senbabaoglu, F.; Cingoz, A.; Kaya, E.; Kazancioglu, S.; Lack, N.; Acilan, C.; Bagci-Onder, T.